Researchers examined whether pharmacist-led interventions improved adherence to medications and guideline-concordant care based on changes in hemoglobin A1C (HbA1C) levels and systolic blood pressure among Hispanic type 2 diabetes patients.
Amgen names Stanford geneticist and biotech founder to CSO post
Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS